| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.72e-05 | 18 | 66 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 6.43e-05 | 4 | 66 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | cullin family protein binding | 8.49e-05 | 26 | 66 | 3 | GO:0097602 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.45e-04 | 31 | 66 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.60e-04 | 6 | 66 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.75e-04 | 33 | 66 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | calcium ion binding | 7.65e-04 | 749 | 66 | 9 | GO:0005509 | |
| GeneOntologyCellularComponent | AP-5 adaptor complex | 6.42e-05 | 4 | 69 | 2 | GO:0044599 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 4.75e-04 | 10 | 69 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | AP-type membrane coat adaptor complex | 5.35e-04 | 48 | 69 | 3 | GO:0030119 | |
| HumanPheno | Abnormality of lower limb joint | MYL1 PPP2R5D CAPN1 AFF3 OGDHL MACF1 CYP7B1 UMPS PLCB3 UPF3B AP4B1 GPC6 STAG2 RYR1 | 2.20e-05 | 1027 | 23 | 14 | HP:0100491 |
| Domain | - | 4.25e-07 | 261 | 68 | 9 | 1.10.238.10 | |
| Domain | EF-hand-dom_pair | 9.39e-07 | 287 | 68 | 9 | IPR011992 | |
| Domain | EF_hand_dom | 1.96e-06 | 232 | 68 | 8 | IPR002048 | |
| Domain | EF_HAND_2 | 2.06e-05 | 231 | 68 | 7 | PS50222 | |
| Domain | Ryanrecept_TM4-6 | 3.91e-05 | 3 | 68 | 2 | IPR009460 | |
| Domain | RyR | 3.91e-05 | 3 | 68 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 3.91e-05 | 3 | 68 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 3.91e-05 | 3 | 68 | 2 | PF06459 | |
| Domain | Ryan_recept | 3.91e-05 | 3 | 68 | 2 | IPR013333 | |
| Domain | RIH_assoc | 1.94e-04 | 6 | 68 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 1.94e-04 | 6 | 68 | 2 | IPR013662 | |
| Domain | RIH_dom | 1.94e-04 | 6 | 68 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.94e-04 | 6 | 68 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.94e-04 | 6 | 68 | 2 | IPR015925 | |
| Domain | - | 1.94e-04 | 6 | 68 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.94e-04 | 6 | 68 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 1.94e-04 | 6 | 68 | 2 | PF08709 | |
| Domain | ARM-type_fold | 2.29e-04 | 339 | 68 | 7 | IPR016024 | |
| Domain | EF-hand_1 | 2.31e-04 | 152 | 68 | 5 | PF00036 | |
| Domain | EF-hand_8 | 2.55e-04 | 34 | 68 | 3 | PF13833 | |
| Domain | EFh | 2.76e-04 | 158 | 68 | 5 | SM00054 | |
| Domain | ARM-like | 4.46e-04 | 270 | 68 | 6 | IPR011989 | |
| Domain | Keratin_I | 5.49e-04 | 44 | 68 | 3 | IPR002957 | |
| Domain | MIR | 5.77e-04 | 10 | 68 | 2 | PS50919 | |
| Domain | MIR | 5.77e-04 | 10 | 68 | 2 | PF02815 | |
| Domain | MIR | 5.77e-04 | 10 | 68 | 2 | SM00472 | |
| Domain | MIR_motif | 5.77e-04 | 10 | 68 | 2 | IPR016093 | |
| Domain | DOCK_C | 7.03e-04 | 11 | 68 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 7.03e-04 | 11 | 68 | 2 | IPR027007 | |
| Domain | DHR_2 | 7.03e-04 | 11 | 68 | 2 | PS51651 | |
| Domain | DHR_1 | 7.03e-04 | 11 | 68 | 2 | PS51650 | |
| Domain | DOCK-C2 | 7.03e-04 | 11 | 68 | 2 | PF14429 | |
| Domain | DHR-2 | 7.03e-04 | 11 | 68 | 2 | IPR027357 | |
| Domain | DHR-2 | 7.03e-04 | 11 | 68 | 2 | PF06920 | |
| Domain | DOCK | 7.03e-04 | 11 | 68 | 2 | IPR026791 | |
| Domain | Calpain_III | 8.42e-04 | 12 | 68 | 2 | IPR022683 | |
| Domain | calpain_III | 8.42e-04 | 12 | 68 | 2 | SM00720 | |
| Domain | C2_III | 8.42e-04 | 12 | 68 | 2 | IPR033883 | |
| Domain | Calpain_domain_III | 9.93e-04 | 13 | 68 | 2 | IPR022682 | |
| Domain | Calpain_III | 9.93e-04 | 13 | 68 | 2 | PF01067 | |
| Domain | Calpain_cysteine_protease | 1.16e-03 | 14 | 68 | 2 | IPR022684 | |
| Domain | CysPc | 1.33e-03 | 15 | 68 | 2 | SM00230 | |
| Domain | Peptidase_C2_calpain_cat | 1.33e-03 | 15 | 68 | 2 | IPR001300 | |
| Domain | Peptidase_C2 | 1.33e-03 | 15 | 68 | 2 | PF00648 | |
| Domain | CALPAIN_CAT | 1.33e-03 | 15 | 68 | 2 | PS50203 | |
| Domain | Filament | 2.21e-03 | 71 | 68 | 3 | SM01391 | |
| Domain | IF | 2.30e-03 | 72 | 68 | 3 | PS00226 | |
| Domain | Filament | 2.39e-03 | 73 | 68 | 3 | PF00038 | |
| Domain | IF | 2.68e-03 | 76 | 68 | 3 | IPR001664 | |
| Domain | Actinin_actin-bd_CS | 3.15e-03 | 23 | 68 | 2 | IPR001589 | |
| Domain | Spectrin | 3.15e-03 | 23 | 68 | 2 | PF00435 | |
| Domain | ACTININ_2 | 3.15e-03 | 23 | 68 | 2 | PS00020 | |
| Domain | ACTININ_1 | 3.15e-03 | 23 | 68 | 2 | PS00019 | |
| Domain | EF_Hand_1_Ca_BS | 3.80e-03 | 175 | 68 | 4 | IPR018247 | |
| Domain | THIOL_PROTEASE_CYS | 4.01e-03 | 26 | 68 | 2 | PS00139 | |
| Domain | THIOL_PROTEASE_ASN | 4.32e-03 | 27 | 68 | 2 | PS00640 | |
| Domain | THIOL_PROTEASE_HIS | 4.32e-03 | 27 | 68 | 2 | PS00639 | |
| Domain | Pept_cys_AS | 4.64e-03 | 28 | 68 | 2 | IPR000169 | |
| Domain | Spectrin_repeat | 4.98e-03 | 29 | 68 | 2 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 6.04e-03 | 32 | 68 | 2 | IPR018159 | |
| Domain | SPEC | 6.04e-03 | 32 | 68 | 2 | SM00150 | |
| Pubmed | 2.60e-07 | 7 | 69 | 3 | 20962236 | ||
| Pubmed | 3.34e-06 | 15 | 69 | 3 | 10087197 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 17259277 | ||
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 3.88e-06 | 2 | 69 | 2 | 14722100 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 3.88e-06 | 2 | 69 | 2 | 26009179 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 32899693 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 30542613 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 15280431 | ||
| Pubmed | Expression of the ryanodine receptor isoforms in immune cells. | 3.88e-06 | 2 | 69 | 2 | 11673493 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 11673462 | ||
| Pubmed | Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. | 3.88e-06 | 2 | 69 | 2 | 25370123 | |
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 3.88e-06 | 2 | 69 | 2 | 15033925 | |
| Pubmed | Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels. | 3.88e-06 | 2 | 69 | 2 | 18618700 | |
| Pubmed | 4.73e-06 | 638 | 69 | 9 | 31182584 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 18403125 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 38251918 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 7535287 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 18434746 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 1.16e-05 | 3 | 69 | 2 | 9204703 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 7876312 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 21881589 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 24123915 | ||
| Pubmed | The structural basis for the interaction between nonsense-mediated mRNA decay factors UPF2 and UPF3. | 1.16e-05 | 3 | 69 | 2 | 15004547 | |
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 1.16e-05 | 3 | 69 | 2 | 12213830 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 28330868 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 23278119 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 9242641 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 22948152 | ||
| Pubmed | Direct association of the reticulon protein RTN1A with the ryanodine receptor 2 in neurons. | 1.16e-05 | 3 | 69 | 2 | 23454728 | |
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 1.16e-05 | 3 | 69 | 2 | 10788707 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 25239916 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 1.16e-05 | 3 | 69 | 2 | 7621815 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 35640974 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 18643873 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 11159936 | ||
| Pubmed | PPARγ deacetylation dissociates thiazolidinedione's metabolic benefits from its adverse effects. | 1.16e-05 | 3 | 69 | 2 | 29589839 | |
| Pubmed | Intracellular calcium release channel expression during embryogenesis. | 1.16e-05 | 3 | 69 | 2 | 9986730 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 12718880 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 1.16e-05 | 3 | 69 | 2 | 10473538 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 1.16e-05 | 3 | 69 | 2 | 4600883 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 7635066 | ||
| Pubmed | 1.72e-05 | 160 | 69 | 5 | 31678930 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | KCTD6 KRT13 PPP2R5D KRT15 MACF1 PRMT1 SRPRA PLCB3 UPF3B MTCL1 EIF3D STAG2 | 2.02e-05 | 1415 | 69 | 12 | 28515276 |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 18206662 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 22504960 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 22022230 | ||
| Pubmed | A UPF3-mediated regulatory switch that maintains RNA surveillance. | 2.32e-05 | 4 | 69 | 2 | 19503078 | |
| Pubmed | Calmodulin modulates the termination threshold for cardiac ryanodine receptor-mediated Ca2+ release. | 2.32e-05 | 4 | 69 | 2 | 23992453 | |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 2.32e-05 | 4 | 69 | 2 | 23413940 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 11516996 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 9384575 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 11113196 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 9607712 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 27226555 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 19120137 | ||
| Pubmed | FKBP binding characteristics of cardiac microsomes from diverse vertebrates. | 2.32e-05 | 4 | 69 | 2 | 11237759 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 23482488 | ||
| Pubmed | Role of leaky neuronal ryanodine receptors in stress-induced cognitive dysfunction. | 3.86e-05 | 5 | 69 | 2 | 22939628 | |
| Pubmed | Intracellular calcium-release channels: regulators of cell life and death. | 3.86e-05 | 5 | 69 | 2 | 9124414 | |
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 23918386 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 17646163 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 12823437 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 12723973 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 11163187 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 18369367 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 3.86e-05 | 5 | 69 | 2 | 19011160 | |
| Pubmed | Diversification of stem cell molecular repertoire by alternative splicing. | 4.67e-05 | 35 | 69 | 3 | 16183747 | |
| Pubmed | 5.79e-05 | 496 | 69 | 7 | 31343991 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 19549818 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 5.79e-05 | 6 | 69 | 2 | 26025922 | |
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 23463619 | ||
| Pubmed | The cryo-EM structure of the UPF-EJC complex shows UPF1 poised toward the RNA 3' end. | 5.79e-05 | 6 | 69 | 2 | 22522823 | |
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 5.79e-05 | 6 | 69 | 2 | 14592808 | |
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 5.79e-05 | 6 | 69 | 2 | 25966694 | |
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 19009018 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 12554878 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 20479275 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 5.79e-05 | 6 | 69 | 2 | 16844763 | |
| Pubmed | 5.86e-05 | 497 | 69 | 7 | 23414517 | ||
| Pubmed | 6.38e-05 | 686 | 69 | 8 | 28380382 | ||
| Pubmed | 8.09e-05 | 7 | 69 | 2 | 12417715 | ||
| Pubmed | 8.09e-05 | 7 | 69 | 2 | 11860456 | ||
| Pubmed | 8.09e-05 | 7 | 69 | 2 | 18256688 | ||
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 18066079 | ||
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 19478851 | ||
| Pubmed | Mammalian Staufen1 recruits Upf1 to specific mRNA 3'UTRs so as to elicit mRNA decay. | 1.08e-04 | 8 | 69 | 2 | 15680326 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.08e-04 | 8 | 69 | 2 | 19033399 | |
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 9933612 | ||
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 16209946 | ||
| Pubmed | ORAI1, STIM1/2, and RYR1 shape subsecond Ca2+ microdomains upon T cell activation. | 1.08e-04 | 8 | 69 | 2 | 30563862 | |
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 11784029 | ||
| Pubmed | Functions of hUpf3a and hUpf3b in nonsense-mediated mRNA decay and translation. | 1.08e-04 | 8 | 69 | 2 | 16601204 | |
| Pubmed | 1.29e-04 | 49 | 69 | 3 | 24378760 | ||
| Pubmed | eIF4G is required for the pioneer round of translation in mammalian cells. | 1.38e-04 | 9 | 69 | 2 | 15361857 | |
| Pubmed | 1.38e-04 | 9 | 69 | 2 | 12093754 | ||
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 11546874 | ||
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 18434328 | ||
| Pubmed | The RNA helicase Ddx5/p68 binds to hUpf3 and enhances NMD of Ddx17/p72 and Smg5 mRNA. | 1.73e-04 | 10 | 69 | 2 | 23788676 | |
| Cytoband | 7p22.2 | 9.94e-05 | 10 | 69 | 2 | 7p22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q13 | 6.18e-04 | 454 | 69 | 5 | chr11q13 | |
| Cytoband | 10q11.23 | 1.14e-03 | 33 | 69 | 2 | 10q11.23 | |
| Cytoband | 11q22.3 | 2.02e-03 | 44 | 69 | 2 | 11q22.3 | |
| Cytoband | 2p21 | 3.85e-03 | 61 | 69 | 2 | 2p21 | |
| GeneFamily | EF-hand domain containing | 3.85e-07 | 219 | 39 | 7 | 863 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.36e-05 | 3 | 39 | 2 | 287 | |
| GeneFamily | Keratins, type I | 2.93e-05 | 28 | 39 | 3 | 608 | |
| GeneFamily | C2 domain containing|Calpains | 4.68e-04 | 15 | 39 | 2 | 975 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 3.38e-02 | 134 | 39 | 2 | 861 | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 4.31e-07 | 185 | 69 | 6 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | COPD-Lymphoid-B|World / Disease state, Lineage and Cell class | 4.31e-07 | 185 | 69 | 6 | 22891ed75e25ef30dfa541cb82d85e08ce07e7d9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.52e-07 | 193 | 69 | 6 | 9f798a1bbd9f076c3122d02ed28418c18bb7a369 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.04e-07 | 196 | 69 | 6 | f37ffb916480281e5905733ac304102dd2e0c05f | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_mature|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.04e-07 | 196 | 69 | 6 | 4b9eb163b9dbbf5eebb160f6554f6f28cb234d31 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-06 | 141 | 69 | 5 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-06 | 141 | 69 | 5 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-06 | 163 | 69 | 5 | 8028636632c168dc50731d0ebecaf88a70daf81d | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 5.98e-06 | 166 | 69 | 5 | 8de8f388f24436b84e19ef460476fdbda4d16abf | |
| ToppCell | facs-Kidney-nan-24m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-06 | 167 | 69 | 5 | 3c4183a8225bae37b9f5341ebd1b95409ced2022 | |
| ToppCell | facs-Kidney-nan-24m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-06 | 167 | 69 | 5 | 28e9670586ff551b700c794313d27eedbfa1286b | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.34e-06 | 168 | 69 | 5 | 9b8a74abb83c64f0b5829dcb4275f722c82b45dc | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.34e-06 | 168 | 69 | 5 | 4b152b8d0f4a66faf664dfacb7914b18d60ce64a | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.34e-06 | 168 | 69 | 5 | c3169ad8f4130ef18777ed86770bb722ffb5db85 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Trh_(Substantia_Innominata_(SI))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.09e-06 | 82 | 69 | 4 | 73349906bcc8d1a40dc03df7a490a963e85564f2 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Trh_(Substantia_Innominata_(SI))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.09e-06 | 82 | 69 | 4 | 15bc417aaace2b1d680904a622fe76e95083c9ff | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Trh_(Substantia_Innominata_(SI))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.09e-06 | 82 | 69 | 4 | 697e1da3095c8483b8181b290fa5417bdc9cee54 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-FCRL4+_Memory_B|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.85e-06 | 180 | 69 | 5 | eedb6d89680f968167afb1dcd132c9de9096b50f | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.10e-06 | 181 | 69 | 5 | 8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-06 | 182 | 69 | 5 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-06 | 182 | 69 | 5 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.34e-06 | 182 | 69 | 5 | 678eadd57e7e830fc2bf9fd35616d3badce01705 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-06 | 182 | 69 | 5 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.34e-06 | 182 | 69 | 5 | 8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.85e-06 | 184 | 69 | 5 | f81209e6bc01a0140f4487aa8b22eb02fbf0c39c | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 185 | 69 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 185 | 69 | 5 | c083a4974590b9ed3ecafedd3e9cdebc5047fe39 | |
| ToppCell | COVID-19-lung-B_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.01e-05 | 185 | 69 | 5 | e8f1ad580f19705b5ca1d7d8867b2125f4891684 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 187 | 69 | 5 | 8fa454dc4e6a3e8e2bb2ad803acc579e0d3f76da | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 187 | 69 | 5 | edad646d5eb1d70b768dc21fe02ef5265214e8e6 | |
| ToppCell | facs-Skin-Anagen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 189 | 69 | 5 | adbfc723130079b4caf551f66d2aee86fab1903c | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 190 | 69 | 5 | 888ded899f0513d41bf655896d59ae8ef74e0978 | |
| ToppCell | BLOOD--(3)_MNP-(3)_DC_(cDC+pDC)|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.15e-05 | 190 | 69 | 5 | 9b8de47f7a2e6137d934ccce32417ab15eb54f46 | |
| ToppCell | facs-Skin-Anagen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 190 | 69 | 5 | 3466cebab16964e94da130d0673fa32e7d90b5ed | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 1.15e-05 | 190 | 69 | 5 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.24e-05 | 193 | 69 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.24e-05 | 193 | 69 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 193 | 69 | 5 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 1.24e-05 | 193 | 69 | 5 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | severe_COVID-19-B_intermediate|World / disease group, cell group and cell class (v2) | 1.27e-05 | 194 | 69 | 5 | cb346cb186fe80a8f490ae90b2539b3543ba0ca9 | |
| ToppCell | severe_COVID-19-B_intermediate|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.37e-05 | 197 | 69 | 5 | 3ba64850b344cb24a4d20d64392a0b2752950d40 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.47e-05 | 200 | 69 | 5 | be1abe5bb1ce4e7dfec63af4ed0fc5b96bf77866 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 5.76e-05 | 135 | 69 | 4 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-05 | 142 | 69 | 4 | 759fbbd15b4fb313bd6269b7f087edafebd530ef | |
| ToppCell | TCGA-Breast|World / Sample_Type by Project: Shred V9 | 8.67e-05 | 150 | 69 | 4 | 08686ba1acac5c58667bf62e2af84c691d6bbdfb | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 156 | 69 | 4 | 2ba838bc864c2c1767bcab7bb4d790af96b91387 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC1|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 158 | 69 | 4 | c276a259e20ee704e2d04baf693e8d677f96f654 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 159 | 69 | 4 | 0c2437da5443fc3aff66f8ef311f02aa434a1fb0 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|World / disease group, cell group and cell class (v2) | 1.11e-04 | 160 | 69 | 4 | 6722934e153b72039c3c4308557d0ef879a30638 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.14e-04 | 161 | 69 | 4 | 63f0b97c741b610c450f65fa5764d712bfe09ce8 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 161 | 69 | 4 | 1011094c54381d52566e24c92f89f2efc2aa3eea | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 162 | 69 | 4 | 6972d45f4bd4b6522bf93295f7e9dca7c6cba1f3 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-04 | 163 | 69 | 4 | 299ac2463b7f58eee419d822a2a2d64b973d87e9 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 165 | 69 | 4 | 936581de8fcd097401707438b9bbe89dd4e3e247 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 167 | 69 | 4 | f33cef917fa733adf6d5a9a9e989a4d9fd462a8f | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 1.34e-04 | 168 | 69 | 4 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-04 | 168 | 69 | 4 | d6078e3a79d315d6090906e171a7d67a9206b2c7 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 168 | 69 | 4 | 35ce3b2b9c9997d4c101da5949c7271d6a6b8f12 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 168 | 69 | 4 | 96f7411474edd673b8d3ee6b8a8bb185c246daaf | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 169 | 69 | 4 | 305cedbd97059029d7d2a248a8a4b6cfe281aa54 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 169 | 69 | 4 | 08ac28c5ad8f5c5f9f54af341bf39e8f9417636e | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-04 | 169 | 69 | 4 | 225aec04ba762d4c55885257de03a65b63503fbb | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-04 | 169 | 69 | 4 | 278960f940b646a788360b1c84d641a8d169896b | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 169 | 69 | 4 | e5abd41db1e6724ad900e37658fa063b8e522908 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-04 | 170 | 69 | 4 | a965e3ee6818790a4a6916824fde64333d9b11b7 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 170 | 69 | 4 | 71c52fadecc6b4bfe98692b266adaa1406f6d56d | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.40e-04 | 170 | 69 | 4 | e421f9eedf74baffda1d03707a710ece4b777f29 | |
| ToppCell | COVID-19-kidney-Bcells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.44e-04 | 171 | 69 | 4 | 8e8fb79968b1a5c34d1d9cad7f9155fabfdb7cc7 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.47e-04 | 172 | 69 | 4 | e9095c3dac66cf93d31f5f88364b565abacb1e2d | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 172 | 69 | 4 | 4d04df9776394ea156ed5822f92ae74fdefbaa3d | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 172 | 69 | 4 | 3acf35b774ebc0f9e96299d0bd3e9d03bbf6b90c | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.50e-04 | 173 | 69 | 4 | f66aebceb3eb389bc5ff6c0b398d6f4e9959a14f | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.57e-04 | 175 | 69 | 4 | 1b3510e9078eec7cfc5805043e435e9e5e0f0877 | |
| ToppCell | IIF-Lymphocyte-B-B_intermediate|IIF / Disease, Lineage and Cell Type | 1.57e-04 | 175 | 69 | 4 | 327f8ee3669c3fc5ba50abc3b4f3e068637fd8d8 | |
| ToppCell | COVID-mDC1-|COVID / Condition, Cell_class and T cell subcluster | 1.57e-04 | 175 | 69 | 4 | 83a95d6fc2ddf3ec53f05825bbc982fb8d2ccd15 | |
| ToppCell | COVID-mDC1|COVID / Condition, Cell_class and T cell subcluster | 1.57e-04 | 175 | 69 | 4 | b9280444016e21c28131a61df65cc5c56d402412 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.60e-04 | 176 | 69 | 4 | 7b5e50eb144bf43ca0cf354a466eb58b976a79f1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 176 | 69 | 4 | 274458d80f9f3f080248cbf64e4784ef351e7254 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-04 | 176 | 69 | 4 | ed7ba2a3af3b060dec98b60f09f96000a67f7e63 | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 1.60e-04 | 176 | 69 | 4 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-04 | 176 | 69 | 4 | 238244294d08975df6bfa26b2b437db3654408ae | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 176 | 69 | 4 | d0a3e176df1270968efa79c00dc941c5e1c4f7aa | |
| ToppCell | COVID-19-Myeloid-MoAM4|COVID-19 / Condition, Lineage and Cell class | 1.64e-04 | 177 | 69 | 4 | ca5d0c3d5c700bbe4c2da068eb02be6229afb9a0 | |
| ToppCell | COVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type | 1.64e-04 | 177 | 69 | 4 | f54691e5558091c1734ab15153a10bff15ed171e | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 177 | 69 | 4 | 7bc92314b22a876296a4e2db51e7fb0fdfd69379 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 177 | 69 | 4 | b07e6139618d888a9fd7cf43cad0d86a3f63e09e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.64e-04 | 177 | 69 | 4 | 37d1abe1a9d8f2b8f4d146bbf1db94104eab6593 | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 1.64e-04 | 177 | 69 | 4 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 177 | 69 | 4 | 6376ec12322c04d5d37ec2fdc376700464cbc7fb | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 177 | 69 | 4 | 3cb96d7d56c9ff90f1f8a6caaf49e580e2524c7d | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.68e-04 | 178 | 69 | 4 | be1d991c5a0a5be22f14f57d34ee1330f1a12963 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 178 | 69 | 4 | 8aef208b6351143562c87715bb11628880abce94 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-04 | 178 | 69 | 4 | b7d1d8f76c1c2467b1a39a9b4150ed4a47144a15 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-04 | 179 | 69 | 4 | 33ed9270d257895ff3b40df2c1af878119c9f492 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-04 | 179 | 69 | 4 | 716856b2c7c660bf5ce00e63efeda6ed121f2baa | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 179 | 69 | 4 | 30efe1f0394c0edb27b91890b5c4637b73cbc5ec | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-04 | 179 | 69 | 4 | b7a2429d07d7146b32b3552a5f2a2542105a71e0 | |
| ToppCell | normal_Lung-B_lymphocytes|normal_Lung / Location, Cell class and cell subclass | 1.71e-04 | 179 | 69 | 4 | 5b89193486100b6754c1c5eca3105ea955805eae | |
| ToppCell | IPF-Lymphoid-B|World / Disease state, Lineage and Cell class | 1.75e-04 | 180 | 69 | 4 | 30f9398c9b784f49470847a025bac90687e997a1 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.75e-04 | 180 | 69 | 4 | 8e96f8646c002768b272359af485dc0ab57e0ccd | |
| Drug | Proguanil hydrochloride [637-32-1]; Down 200; 13.8uM; HL60; HT_HG-U133A | 2.16e-06 | 196 | 69 | 7 | 2944_DN | |
| Drug | R 478 | 4.32e-06 | 11 | 69 | 3 | CID000084223 | |
| Drug | 2-hydroxycarbazole | 2.71e-05 | 3 | 69 | 2 | CID000093551 | |
| Drug | cis-diammineplatinum(II | 2.71e-05 | 3 | 69 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 2.71e-05 | 3 | 69 | 2 | CID002750949 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 2.71e-05 | 3 | 69 | 2 | CID005748312 | |
| Drug | 8N3-cADPR | 2.71e-05 | 3 | 69 | 2 | CID000127713 | |
| Drug | aminodantrolene | 2.71e-05 | 3 | 69 | 2 | CID009570289 | |
| Drug | PCB74 | 5.41e-05 | 4 | 69 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 5.41e-05 | 4 | 69 | 2 | CID006444275 | |
| Drug | SC 38249 | 5.41e-05 | 4 | 69 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 5.41e-05 | 4 | 69 | 2 | CID000035682 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.43e-05 | 3 | 65 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.43e-05 | 3 | 65 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | hereditary spastic paraplegia 76 (implicated_via_orthology) | 4.76e-05 | 5 | 65 | 2 | DOID:0110821 (implicated_via_orthology) | |
| Disease | Congenital myopathy (disorder) | 3.11e-04 | 12 | 65 | 2 | C0270960 | |
| Disease | mean platelet volume | 3.83e-04 | 1020 | 65 | 9 | EFO_0004584 | |
| Disease | eating disorder, bipolar disorder | 4.27e-04 | 14 | 65 | 2 | EFO_0005203, MONDO_0004985 | |
| Disease | Intellectual Disability | 4.54e-04 | 447 | 65 | 6 | C3714756 | |
| Disease | serum IgG measurement | 7.15e-04 | 18 | 65 | 2 | EFO_0004565 | |
| Disease | response to methotrexate, neurotoxicity | 7.98e-04 | 19 | 65 | 2 | EFO_0011057, GO_0031427 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 8.97e-04 | 194 | 65 | 4 | EFO_0004265, EFO_0007908 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.47e-03 | 222 | 65 | 4 | EFO_0008317, EFO_0020943 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.55e-03 | 225 | 65 | 4 | EFO_0008317, EFO_0020947 | |
| Disease | Child Development Disorders, Specific | 1.87e-03 | 29 | 65 | 2 | C0085997 | |
| Disease | Child Development Deviations | 1.87e-03 | 29 | 65 | 2 | C0085996 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.93e-03 | 239 | 65 | 4 | EFO_0008317, EFO_0020945 | |
| Disease | Developmental Disabilities | 2.00e-03 | 30 | 65 | 2 | C0008073 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LAKENREFFNDLDLL | 1181 | P51826 | |
| DLDENQLKDEFFKLL | 171 | Q9H993 | |
| ELDRFKFFLSDEFNI | 21 | O14862 | |
| EELFDILNLLDSFLK | 231 | Q9Y6B7 | |
| AALFLEKVRDLDDFL | 346 | Q9H221 | |
| DQKFVLALLDLFDSE | 236 | Q14738 | |
| QINKFFEALEALLFE | 666 | O43299 | |
| DQEDDQFRRLFEKLA | 531 | A6NHC0 | |
| EEIDENFKALFRQLA | 541 | P07384 | |
| FLEAIDLREDKDFLE | 111 | P51861 | |
| FDFARDKDQRSLDID | 146 | Q9BTE7 | |
| RLNVDQDALFFLKDF | 1586 | Q2TAZ0 | |
| AKNNRDLDFTIDLDF | 341 | Q99873 | |
| VQKFFADFLLAEDDI | 416 | Q8IXT5 | |
| AFKALLEDFRAELRE | 1141 | Q9Y4B5 | |
| AADDFRLKYENELAL | 186 | P13646 | |
| LKDLFRDFDITGDNR | 141 | A8MZ26 | |
| FYDLQEADLDKEFQL | 161 | Q9ULD0 | |
| ARLTADDFRLKFENE | 166 | Q7Z3Y8 | |
| DDFRLKFENELALHQ | 171 | Q7Z3Y8 | |
| LDRLEELKEFANFDF | 3141 | O94854 | |
| NEFFQVLDDLDSKLA | 206 | Q8NEV8 | |
| LAADDFRLKYENELA | 186 | P19012 | |
| QQDEFKEAFLLFDRT | 51 | P05976 | |
| LFELRLLDDDKDFVE | 56 | Q9H0R1 | |
| EFLERLNLFLEKEGQ | 101 | Q9UL42 | |
| VEKLNEAFDILLAFF | 521 | Q7Z2Q7 | |
| NDALDRLEELKEFAN | 7011 | Q9UPN3 | |
| RLEELKEFANFDFDV | 7016 | Q9UPN3 | |
| EDLLQADFEGALKFF | 741 | Q5R372 | |
| RTLDNQLFFFLVEDD | 691 | P26010 | |
| DEFSLEIFERFLNKL | 206 | Q01970 | |
| FKNQEDIILFRDRFD | 101 | Q9BZI7 | |
| DEFFRELLENAEKSL | 106 | Q9Y625 | |
| DVRDAAAEFLEKNLF | 131 | Q9H0H3 | |
| LSDALRKNFLNENFD | 986 | Q8N1I0 | |
| FFKQEGDRLSDEDLF | 471 | Q8NF50 | |
| LDEFDQFIRKSLSFL | 871 | Q9UFH2 | |
| DLEECLKFLNFFKDN | 321 | P56159 | |
| KERFAFLFNSELLSD | 56 | Q9H0C5 | |
| LFFDKRDNSDFDLLT | 276 | O15371 | |
| ENLELDEFLFLEQAA | 571 | Q9HC77 | |
| FFHEREDLEFKINEL | 376 | Q8IWJ2 | |
| DQKALLEFRDTIFDN | 86 | Q03113 | |
| LDFKEFDLLRKEADF | 81 | Q8NC69 | |
| NKFISELRDDFLKFD | 206 | O75881 | |
| EDFEKEFSFLNNLLS | 341 | Q8NDH6 | |
| LRFADEFNKLAEDFL | 276 | Q86WA6 | |
| LEEDSALEALLNFFF | 116 | Q8N0W7 | |
| DDEFTQDLFRFLQLL | 3876 | P21817 | |
| ALRAFLDNAAEDLEK | 3056 | Q92736 | |
| FAENELDLFRKALEL | 101 | Q8WV22 | |
| DLEEAFKLFNLAKDI | 36 | Q2NKX8 | |
| DEDARNFYENLIDLK | 461 | Q9HAU5 | |
| DNESELLRLKAFILF | 1481 | A6NES4 | |
| NLIILLEDEVFADFF | 11 | A5PLK6 | |
| LLELKREFAFDDALR | 411 | Q3MII6 | |
| DRLIALDAAEEFFKL | 171 | Q8N565 | |
| KFNALELDDSDLAIF | 401 | P37231 | |
| FLKNDDLIIFVDFED | 581 | Q16819 | |
| DNRKLFEAEEQDLFR | 266 | Q9NZN3 | |
| KDEAENAFLLEELFA | 1291 | Q13018 | |
| ARSLLLKFFRDADEE | 2891 | Q9NRC6 | |
| RQALFKLDNEDGFEE | 616 | Q9HAW4 | |
| LADKFNRLLEDFLQE | 661 | Q8N3U4 | |
| REKNRECILLDFFDD | 776 | Q9NXL6 | |
| FFRRNGLFEKLAEDL | 701 | Q6ZS81 | |
| EFLIFEDRKFADIGN | 306 | P11172 | |
| FDFQNDFLRLLREAE | 111 | P08240 | |
| LLFDDEQFVVKAFRL | 166 | Q9H777 | |
| ELNFKDAFDSFERLK | 366 | Q8N584 | |
| DFKLLEFLDLSFNSL | 161 | Q6P2D8 | |
| LSAEEFQKLFNELDR | 391 | Q8NHX9 |